According to a new study reported in the American Journal of Therapeutics (1), the prevalence of traditional hormone replacement therapy is declining in the general population. The trend is primarily attributed to the health related adverse effects of conventional HRT, reported in several clinical trials and research studies. Data indicates that current prevalence of HRT use is 12%, as opposed to 45% in 1996 (2).

Based on the recent estimates, each day approximately 6000 females reach natural menopause within United States.

According to latest projections, the population of females older than 55 years will cross 46 million in United States alone.

With the declining levels of female sexual hormones, a number of women develop disturbing symptoms like insomnia, hot flashes, sexual dysfunction, sagging of breast and skin, osteoporosis and cardiovascular diseases. The information above entails the need and requirement of a safe, effective and reliable therapeutic option to maintain the quality of life in females even after menopause.